TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+125.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.97B
AUM Growth
-$55.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
79
New
Increased
Reduced
Closed

Top Buys

1
+$93.8M
2
+$50.2M
3
+$45.3M
4
INSM icon
Insmed
INSM
+$30.7M
5
CMPS
Compass Pathways
CMPS
+$26.9M

Top Sells

1
+$64.9M
2
+$36.3M
3
+$27.7M
4
TVTX icon
Travere Therapeutics
TVTX
+$26.7M
5
VTYX
Ventyx Biosciences
VTYX
+$25.4M

Sector Composition

1 Healthcare 94.45%
2 Communication Services 0%
3 Real Estate 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
1
Aurinia Pharmaceuticals
AUPH
$2.11B
$181M 9.2%
12,229,500
+900,000
CELC icon
2
Celcuity
CELC
$4.51B
$120M 6.09%
1,050,000
MIRM icon
3
Mirum Pharmaceuticals
MIRM
$5.64B
$114M 5.8%
1,236,027
LKFT
4
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.85B
$114M 5.77%
3,785,991
-135,228
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$109M 5.55%
168,000
+138,000
KNSA icon
6
Kiniksa Pharmaceuticals
KNSA
$3.79B
$109M 5.53%
2,259,889
CAPR icon
7
Capricor Therapeutics
CAPR
$1.62B
$103M 5.25%
3,399,900
+1,699,900
PTCT icon
8
PTC Therapeutics
PTCT
$5.86B
$102M 5.19%
1,500,000
SYRE icon
9
Spyre Therapeutics
SYRE
$6.82B
$95.4M 4.85%
1,892,200
KALV icon
10
KalVista Pharmaceuticals
KALV
$1.43B
$92.1M 4.68%
4,573,530
CMPX icon
11
Compass Therapeutics
CMPX
$384M
$88.8M 4.51%
16,790,809
TARS icon
12
Tarsus Pharmaceuticals
TARS
$2.6B
$83.4M 4.23%
1,188,624
IMCR icon
13
Immunocore
IMCR
$1.46B
$79.9M 4.06%
2,649,368
+20,830
ANAB icon
14
AnaptysBio
ANAB
$1.5B
$73.8M 3.75%
1,330,879
-1,208
CORT icon
15
Corcept Therapeutics
CORT
$8.04B
$60.5M 3.07%
1,500,000
+1,343,236
ANIP icon
16
ANI Pharmaceuticals
ANIP
$1.8B
$54.4M 2.76%
707,500
+226,063
INSM icon
17
Insmed
INSM
$22.7B
$42.5M 2.16%
260,000
+200,000
BNTX icon
18
BioNTech
BNTX
$22.7B
$41.8M 2.12%
470,000
VRDN icon
19
Viridian Therapeutics
VRDN
$1.83B
$35.1M 1.78%
1,792,626
AVIR icon
20
Atea Pharmaceuticals
AVIR
$354M
$25.9M 1.32%
4,814,700
PGEN icon
21
Precigen
PGEN
$1.38B
$24.8M 1.26%
6,417,500
+800,000
DNTH icon
22
Dianthus Therapeutics
DNTH
$4.6B
$22.2M 1.13%
264,692
CMPS
23
Compass Pathways
CMPS
$1.76B
$22.1M 1.12%
+4,002,200
CBIO
24
Crescent Biopharma
CBIO
$509M
$21.3M 1.08%
1,160,000
+287,602
STOK icon
25
Stoke Therapeutics
STOK
$1.88B
$16.3M 0.83%
500,000
1
2 3 4